The Johns Hopkins University School of Medicine, USA
view profile
Michel Baudry
Western University of Health Sciences , USA
view profile
Arnal Nathalie
INIBIOLP, Argentina
view profile
Raja Banerjee
MAKAUT, India
view profile
Suman Jain
AIIMS, India
view profile
Joanna Jurek
VHIR, Spain
view profile
Clifford R. Jack,
Mayo Clinic, USA
view profile
Ching-Chi Hsu
Wizcare Medical Corporation Aggregate, Taiwan
view profile
Caroline Jose,
Vital ité Health Network, , Canada
view profile
José Julio Rodríguez Arellano
IKERBASQUE, Spain
view profile
Jiawei Xin
Fujian Medical University , China
view profile
Pat Schofield
University of Plymouth, UK
view profile
Illana Gozes
Tel Aviv University, Israel
view profile
Paul Chazot
Durham University, UK
view profile
Christakis Damianou
Cyprus University of Technology, Cyprus
view profile
Charles R Joseph
Liberty University College of Osteopathic Medicine, USA
view profile
Antonio Carlo GALOFORO
University of Pavia, Italy
Xiaolei Liu Sichuan University, China
The associations of daytime napping and motoric cognitive risk syndrome: Findings from the China Health and Retirement Longitudinal Study
Title of speech: The Associations of daytime napping and Motoric Cognitive Risk Syndrome: Findings from the China Health and Retirement Longitudinal Study
Amanda Myers University of Miami, USA
Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease
Title of speech: Changes in expression of VGF, SPECC1L, HLA-DRA, and RANBP3L act with APOE E4 to alter risk for late-onset Alzheimer’s disease
Kevin K. Wang CNMB, USA
Novel Tau-specific aptamers : diagnostic and therapeutic potentials
KeynoteTalk: Novel Tau-specific aptamers: diagnostic and therapeutic potentials
Alison Buchholz The Johns Hopkins University School of Medicine, USA
A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease
Title of speech: A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease
Michel Baudry Western University of Health Sciences , USA
Can a selective calpain-2 inhibitor be used for the treatment of Alzheimer’s Disease?
KeynoteTalk: Can a selective calpain-2 inhibitor be used for the treatment of Alzheimer’s Disease?
Arnal Nathalie INIBIOLP, Argentina
Potential association of neuronal membrane cholesterol and APP levels with astrocytic de novo cholesterol synthesis, influenced by sex-dependent sublethal copper concentration
Title of speech: Potential association of neuronal membrane cholesterol and APP levels with
astrocytic de novo cholesterol synthesis, influenced by sex-dependent sublethal
copper concentration
Raja Banerjee MAKAUT, India
‘Di-phenylalanine’ unit (FF) acts as the Nucleation site for beta-Amyloid Plaque Formation: Unraveling the Mechanisms of Alzheimer’s Disease
Title of speech: ‘Di-phenylalanine’ unit (FF) acts as the Nucleation site for beta-Amyloid Plaque Formation: Unraveling the Mechanisms of Alzheimer’s Disease
Suman Jain AIIMS, India
Electromagnetic field stimulation ameliorates cognitive deficits and induces neurogenesis in Alzheimer’s disease rat model
Title of speech : Electromagnetic field stimulation ameliorates cognitive deficits and induces neurogenesis in Alzheimer’s disease rat model
Joanna Jurek VHIR, Spain
Restoring Gut-Brain-Immune Axis Homeostasis: The Role of Microbial-Based Interventions in the Management of Gastrointestinal and Systemic Symptoms in ME/CFS and Long COVID
Title of speech: Restoring Gut-Brain-Immune Axis Homeostasis: The Role of Microbial-Based Interventions in the Management of Gastrointestinal and Systemic Symptoms in ME/CFS and Long COVID
Clifford R. Jack, Mayo Clinic, USA
Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
Title of speech: Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
Ching-Chi Hsu Wizcare Medical Corporation Aggregate, Taiwan
Verbal training can improve neurocognitive and reading performance by increasing white matter integrity and grey matter volume
Title of speech: Verbal training can improve neurocognitive and reading performance by
increasing white matter integrity and grey matter volume
Caroline Jose, Vital ité Health Network, , Canada
P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know So Little?
Title of speech: P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know
So Little?
José Julio Rodríguez Arellano IKERBASQUE, Spain
TBA
TBA
Jiawei Xin Fujian Medical University , China
Associations of combined accelerated biological aging and genetic susceptibility with incident dementia: a prospective study in the UK Biobank
Title of speech: Associations of combined accelerated biological aging and genetic susceptibility with incident dementia: a prospective study in the UK Biobank
Pat Schofield University of Plymouth, UK
Pain & Ageing: Where are we now and what needs to be done?
Title of speech: Pain & Ageing: Where are we now and what needs to be done?
Illana Gozes Tel Aviv University, Israel
Keynote Talk: Sex-specific brain protection in the clinical scenario: the case of davuentide
Keynote Talk: Sex-specific brain protection in the clinical scenario: the case of davuentide
Paul Chazot Durham University, UK
In vitro validation of RAR?-M, Ellorarxine, for use in Alzheimers disease
Title of the speech: In vitro validation of RAR?-M, Ellorarxine, for use in Alzheimers disease
Christakis Damianou Cyprus University of Technology, Cyprus
FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice
Title of speech: FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice
Charles R Joseph Liberty University College of Osteopathic Medicine, USA
Cerebral Capillopathy Nexus of Neurodegenerative disease
Title of speech: Cerebral Capillopathy Nexus of Neurodegenerative disease
Antonio Carlo GALOFORO University of Pavia, Italy
OXYGEN-OZONE THERAPY AND COGNITIVE FRAILTY: A NONPHARMACOLOGICAL APPROACH TO POTENTIALLY RESOLVE IMMUNE AND INFLAMMATORY DYSFUNCTIONS
Title of speech: OXYGEN-OZONE THERAPY AND COGNITIVE FRAILTY: A NONPHARMACOLOGICAL
APPROACH TO POTENTIALLY RESOLVE IMMUNE AND INFLAMMATORY DYSFUNCTIONS